Učitavanje...
Predictors of Progression in Barrett’s Esophagus II: Baseline 17p (p53) Loss of Heterozygosity Identifies a Patient Subset at Increased Risk for Neoplastic Progression
OBJECTIVES: Most patients with Barrett’s esophagus do not progress to cancer, but those who do seem to have markedly increased survival when cancers are detected at an early stage. Most surveillance programs are based on histological assessment of dysplasia, but dysplasia is subject to observer vari...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2001
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1808263/ https://ncbi.nlm.nih.gov/pubmed/11693316 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|